DocGo Net Worth
DocGo Net Worth Breakdown | DCGO |
DocGo Net Worth Analysis
DocGo's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including DocGo's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of DocGo's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform DocGo's net worth analysis. One common approach is to calculate DocGo's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares DocGo's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing DocGo's net worth. This approach calculates the present value of DocGo's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of DocGo's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate DocGo's net worth. This involves comparing DocGo's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into DocGo's net worth relative to its peers.
Enterprise Value |
|
To determine if DocGo is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding DocGo's net worth research are outlined below:
| DocGo Inc is unlikely to experience financial distress in the next 2 years | |
| DocGo Inc currently holds about 198.14 M in cash with (64.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.96. | |
| Latest headline from businesswire.com: DocGo Announces Participation at Three Upcoming Investor Conferences |
DocGo Quarterly Good Will |
|
DocGo uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in DocGo Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to DocGo's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 11th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know DocGo's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as DocGo is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DocGo Inc backward and forwards among themselves. DocGo's institutional investor refers to the entity that pools money to purchase DocGo's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Millennium Management Llc | 2024-06-30 | 1.1 M | Franklin Resources Inc | 2024-06-30 | 1.1 M | 1492 Capital Management, Llc | 2024-09-30 | 853.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 770.2 K | Kennedy Capital Management Inc | 2024-06-30 | 712.8 K | Isthmus Partners Llc | 2024-09-30 | 638 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 505.5 K | D. E. Shaw & Co Lp | 2024-06-30 | 505.4 K | Birchview Capital, Lp | 2024-06-30 | 460 K | Deerfield Management Co | 2024-06-30 | 7.2 M | Blackrock Inc | 2024-06-30 | 7 M |
Follow DocGo's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 433.72 M.Market Cap |
|
Project DocGo's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.02 | 0.02 |
When accessing DocGo's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures DocGo's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of DocGo's profitability and make more informed investment decisions.
Evaluate DocGo's management efficiency
DocGo Inc has return on total asset (ROA) of 0.0658 % which means that it generated a profit of $0.0658 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0941 %, meaning that it created $0.0941 on every $100 dollars invested by stockholders. DocGo's management efficiency ratios could be used to measure how well DocGo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to grow to 0.02. Also, Return On Capital Employed is likely to grow to 0.05. At this time, DocGo's Non Currrent Assets Other are very stable compared to the past year. As of the 23rd of November 2024, Other Assets is likely to grow to about 24.6 M, while Total Assets are likely to drop about 306.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.95 | 1.67 | |
| Tangible Book Value Per Share | 2.12 | 1.34 | |
| Enterprise Value Over EBITDA | 17.29 | 18.16 | |
| Price Book Value Ratio | 1.92 | 1.83 | |
| Enterprise Value Multiple | 17.29 | 18.16 | |
| Price Fair Value | 1.92 | 1.83 | |
| Enterprise Value | 565.8 M | 728.2 M |
At DocGo Inc, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 0.5774 | Revenue 695 M | Quarterly Revenue Growth (0.26) | Revenue Per Share 6.752 | Return On Equity 0.0941 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DocGo insiders, such as employees or executives, is commonly permitted as long as it does not rely on DocGo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DocGo insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DocGo Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 1st of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
DocGo Earnings per Share Projection vs Actual
DocGo Corporate Management
| Anthony Capone | President | Profile | |
| Ely Tendler | Secretary Counsel | Profile | |
| Aaron Severs | Chief Officer | Profile | |
| Mike Cole | Vice Relations | Profile | |
| Lee Bienstock | Chief Officer | Profile | |
| Andre CPA | Executive Strategy | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.09 | Earnings Share 0.29 | Revenue Per Share 6.752 | Quarterly Revenue Growth (0.26) | Return On Assets 0.0658 |
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.